The aim of this study was to investigate whether the combination of QRS duration ≥120 ms (wide QRS duration [wQRS]) and late gadolinium enhancement (LGE) is a precise prognostic indicator for dilated cardiomyopathy.
A
ccording to current guidelines, the indications for prophylactic implantable cardioverter defibrillator (ICD) therapy in patients with dilated cardiomyopathy (DCM) are left ventricular ejection fraction (LVEF) ≤35% and New York Heart Association (NYHA) class ≥II.
1,2 However, a recent study showed that prophylactic ICD implantation in patients with nonischemic heart failure (HF) who met the indications mentioned above, a class I recommendation, did not reduce all-cause mortality. 3 Identifying better prognostic factors to more accurately stratify risk in patients with DCM is necessary.
Late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) has emerged as a first-line modality for evaluating prognosis in patients with nonischemic cardiomyopathy. In particular, midwall fibrosis detected with LGE is currently recognized as the most robust outcome predictor. [4] [5] [6] [7] [8] However, LGE is limited in its ability to detect diffuse interstitial fibrosis, which is commonly found in DCM. [9] [10] [11] Thus, the risk of cardiac events in patients with DCM may have been underestimated in prior studies that assessed LGE-positive status alone. 12 Wide QRS duration (wQRS), defined as ≥120 ms on a 12-lead ECG, is a manifestation of intraventricular conduction delay or block. It has been recognized as a simple physiological index for predicting mortality and arrhythmic events in patients with HF. [13] [14] [15] Moreover, a recent study showed that wQRS is associated with diffuse myocardial fibrosis in myotonic muscular dystrophy. 16 We hypothesized that a combination of structural (LGE) and physiological (wQRS) indices might provide more precise risk stratification of cardiac events, including sudden cardiac death (SCD) and all-cause death, than LGE-positive status alone.
WHAT IS KNOWN?
• The DANISH (Danish Study to Assess the Efficacy of implantable cardioverter-defibrillators in Patients with Nonischemic Systolic Heart Failure on Mortality) did not demonstrate lower all-cause mortality in patients with nonischemic heart failure who underwent prophylactic implantable cardioverter-defibrillators implantation (a class I recommendation) despite meeting indications in current US and European guidelines.
• Late gadolinium enhancement (LGE) on cardiac magnetic resonance has emerged as a first-line modality for evaluating prognosis in patients with nonischemic cardiomyopathy; however, LGE has limited ability to detect diffuse interstitial fibrosis, which is commonly found in dilated cardiomyopathy.
WHAT THE STUDY ADDS?
• A combination of structural (LGE status) and physiological (QRS duration) indices provides more precise risk stratification of mortality and sudden cardiac death than LGE-positive status alone.
• In dilated cardiomyopathy patients with a class I indication for implantable cardioverter-defibrillators implantation as primary prevention (left ventricular ejection fraction ≤35% and New York Heart Association class ≥II), the absence of LGE plus wide QRS identifies an additional group who are at low risk of sudden cardiac death and may not benefit from implantable cardioverter-defibrillators implantation.
METHODS
The data that support the findings of this study are available from the corresponding author on reasonable request.
Study Population
We conducted a prospective observational study of 531 consecutive patients with idiopathic DCM at the National Cerebral and Cardiovascular Center in Suita, Japan, between April 2005 and December 2015. The diagnosis of idiopathic DCM was based on World Health Organization criteria and LVEF <50%. 17 All patients underwent invasive coronary angiography or computed tomographic angiography to rule out significant coronary artery stenosis (>50% diameter stenosis). 18 Patients with a history of myocardial infarction or coronary revascularization, myocarditis, hypertrophic cardiomyopathy, secondary cardiomyopathy, valvular heart disease, or hypertensive heart disease or <18 years of age were excluded. CMR imaging and 12-lead electrocardiography were performed while the patient was in a clinically stable, noncongested condition (NYHA class ≤II). None of the patients had a typical subendocardial or transmural LGE pattern in the supplied territory of a coronary artery that might have resulted from myocardial damage secondary to coronary artery disease or coronary embolism. All patients gave written informed consent. The study was approved by the institutional review board and ethics committees of the National Cerebral and Cardiovascular Center.
CMR Protocol
CMR examinations were performed using a 1.5-T system (Magnetom Sonata, Siemens, Erlangen, Germany) with a 4-channel surface coil. The procedures used to acquire MR images in this study have been previously described. 12, 19, 20 Briefly, we identified LGE using a segmented inversion recovery prepared true fast imaging with steady state precession sequence with ECG triggering 10 minutes after the administration of 0.15 mmol/kg body weight of gadolinium diethylenetriamine pentaacetic acid.
LGE Analysis
Two experienced radiologists (Y.M., N.Y.) who were blinded to clinical data and outcomes independently assessed the presence and location of LGE. LGE was only considered present if it was visible in 2 orthogonal views. 6, 21 Interobserver and intraobserver agreement was evaluated for all study patients. The κ values for interobserver and intraobserver agreement for the presence of LGE were 0.87 and 0.90, respectively. A third blinded reader adjudicated in cases with disagreement (4.9%). Midwall LGE was only considered present if the area of LGE was confined to the intermural and subepicardial layers. 6 LGE in multiple territories was defined as diffuse LGE, and isolated LGE was defined as focal LGE.
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ECG Analysis
ECG was performed after 10 minutes of resting in the supine position as part of the initial screening (frequency range, 0.05-150 Hz, 25 mm/s, 10 mm/mV; Fukuda Denshi, Cardio Star FCP-7541, Tokyo, Japan). In patients who had undergone surgical procedures, septal ablation, or pacemaker implantation, ECG was obtained before the procedure or, if no preprocedure ECG was available, patients were excluded from the analysis. The median duration between ECG and CMR was 7 days (interquartile range: 3-15 days). ECG measurements included RR, QT, and QRS intervals. The intervals were automatically analyzed, and wQRS was defined as ≥120 ms. 14, 22 QTc intervals were calculated using Bazett formula. The presence of a complete left bundle branch block, complete right bundle branch block, or interventricular conduction delay was defined according to standard published criteria. 23 The 2 reviewers (K.K., T.K.) were blinded at all times to the patient's clinical history and data to ensure the lack of bias. Figure 1 shows representative CMR and ECG findings according to the presence or absence of LGE and wQRS.
Determination of Brain Natriuretic Peptide
Blood samples were collected in tubes containing EDTA. Plasma brain natriuretic peptide (BNP) levels were measured using a validated commercially available immunoassay kit (Tosoh Co, Tokyo, Japan).
Follow-Up and End Points
After CMR data were obtained, study patients were followed at 3, 6, and 12 months and annually thereafter until the occurrence of any of the following events: all-cause death, SCD, aborted SCD (nonfatal ventricular fibrillation [Vf] , sustained ventricular tachycardia [VT], or appropriate ICD discharge for VT or Vf), cardiac death (HF death, cardiac transplantation, or left ventricular assist device implantation), or rehospitalization for HF. The duration of the follow-up period was calculated from baseline CMR until an end point occurred or last patient contact. The primary end point was all-cause death. The principal secondary end point was composite arrhythmic events consisting of SCD or aborted SCD. Additional secondary end points were cardiac death and rehospitalization for HF. Independent attending cardiologists (E.T., S.Y.) blinded to the patient's baseline LGE status and QRS duration reviewed medical records to determine whether hospitalizations and deaths qualified as cardiac events. SCD was defined as unexpected death either within 1 hour of cardiac symptoms in the absence of progressive cardiac deterioration, during sleep, or within 24 hours of last being seen alive. 24 HF death was defined as death associated with unstable, progressive deterioration of pump function despite active therapy. Aborted SCD was diagnosed in patients who received an appropriate ICD discharge for VT or Vf, including antitachycardia pacing (ATP), or had nonfatal Vf or spontaneous sustained VT (>30 seconds in duration) that caused hemodynamic compromise and required cardioversion. 25 Rehospitalization for HF was defined as hospital admission for signs and symptoms of decompensated HF requiring treatment with an intravenous HF medication (diuretic, vasodilator, or inotropic agent). For composite end points, only the first event for each patient was included in the analysis.
ICD Programing
Regarding ICD programing, before the shock reduction era, the ICD was programmed at the physician's discretion taking patient's background into account. The Vf zone was >188 to 200 beats per minute with at least 1 train of ATP before the shock, and the VT zone was >140 to 160 beats per minute with at least 3 trains of ATP before the shock, which were allowed to be modified according to patient's background. However, after the PREPARE (Primary Prevention Parameters Evaluation), 26 the MADIT-RIT (Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy), 27 the RELEVANT (Role of Long Detection Window Programming in Patients With Left Ventricular Dysfunction, Non-ischemic Etiology in Primary Prevention Treated With a Biventricular ICD), 28 and the ADVANCE III (Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III), 29 we used the long detection interval (eg, 30/40 number of internal detection) and the high detection rate (eg, fast VT ≥182 beats per minute) especially in patients for primary prevention.
Statistical Analysis
All continuous variables are presented as means±SD. Unpaired t tests were used to compare groups. Non-normally distributed variables are presented as medians (interquartile range). ANOVA was used to compare means across multiple groups. Noncontinuous and categorical variables are presented as frequencies or percentages. They were compared using the χ 2 test. If a 3-group comparison was statistically significant, then post hoc pairwise comparisons between each pair were performed to determine which pair was significantly different. The Tukey-Kramer test was used to compare continuous variables, and the χ 2 test with Bonferroni correction was used for categorical variables. Cumulative event-free survival curves were estimated using the Kaplan-Meier method and compared using the logrank test. Univariable Cox proportional hazards regression models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for each end point. Multivariable Cox regression analysis was performed using covariates that significantly predicted each end point in the univariable analysis and established prognostic risk factors for chronic HF (age and sex). Stepwise selection with a P value of 0.1 for backward elimination was used to select the best predictive model. The prognostic value of a combination of LGE status (LGE positive or LGE negative) and QRS status (wQRS or narrow QRS) was compared with LGE status alone using 
C-index.
30 For all variables, we assessed the assumption of proportional hazards by testing for a nonzero slope in a plot of scaled Schoenfeld residuals against time. We then evaluated the discriminatory ability of predictors by comparing the C-index for the combination of LGE and QRS status to the C-index for LGE status or QRS status alone for each end point using Newson method. 31 Reclassification of patient risk was determined using net reclassification improvement (NRI) for each end point. 32 For each patient, the predicted overall risk of an adverse event was determined on the basis of a model that included LVEF, which is an established prognostic index. The relative improvement in patient reclassification associated with LGE status and QRS status was then assessed.
The propensity score adjusted for baseline covariates that were significantly different between the 2 groups or could influence outcomes, including age; sex; NYHA class; heart rate; use of β-blockers, angiotensin-converting enzyme inhibitors, or angiotensin receptor blockers, diuretics, and amiodarone; left and right ventricular ejection fractions; and left ventricular end-diastolic volume index. Propensity scorematched cohorts were constructed to compare the group with 2 negative indices to the group with ≥1 positive indices on a 1:1 basis using the nearest-neighbor matching method within a caliper of 0.01 of the propensity score. Matching was performed using the psmatch2 procedure in STATA. 33 Details on how propensity score matching was performed are described in Table I in the Data Supplement. To compare the prognostic effects of 2 positive indices status between matched pairs, we used shared frailty models, which are used to model within-group correlations. 34, 35 We used the matched pair as the random intercept in a Cox model with the shared option for Cox regression in STATA. All statistical tests were 2 sided, and P<0.05 was regarded as statistically significant. Statistical analysis was performed with JMP, version 13.0.0 (SAS Institute, Cary, NC) and STATA, version 14 (StataCorp LP, College Station, TX).
RESULTS
Baseline Clinical Characteristics
At baseline, 547 patients met the inclusion criteria. The follow-up rate was 97.0%; 16 patients were lost to follow-up. Ultimately, 531 patients were included in the outcome analysis (Figure 2 ), of whom 132 were women. The mean LVEF was 27%.
LGE was presented in 58% of patients, of which 54% was midwall LGE.
We divided study patients into 3 groups according to the presence or absence of LGE and QRS duration as follows: 2 negative indices (LGE negative and narrow QRS; n=162), 1 positive index (either LGE positive or wQRS; n=251), or 2 positive indices (LGE positive and wQRS; n=118). Baseline characteristics of the 3 groups are summarized in Table 1 . Patients in the 2 positive indices group were older (P<0.001) and had higher NYHA class (P<0.001) and BNP levels (P=0.018), lower LVEF (P<0.001), and larger left ventricular volume (P<0.001) compared with the other 2 groups. In contrast, patients in the 2 negative indices group had lower NYHA class and BNP levels and higher LVEF than the other 2 groups. There were no significant differences in the prevalence of the midwall LGE pattern between the 1 positive index group and 2 positive indices group. Within the 1 positive index stratum, there were no significant differences in age, sex, NYHA functional class, BNP, and left ventricular function and volumes between the LGE negative Flow chart detailing the inclusion and exclusion of study patients. Enrolled patients were divided into 3 groups on the basis of late gadolinium enhancement (LGE) status and QRS duration. CMR indicates cardiac magnetic resonance; CTA, computed tomographic angiography; DCM, dilated cardiomyopathy; LGE, late gadolinium enhancement; and LVEF, left ventricular ejection fraction. Current smoker, n (%) 117 (22) 34 (21) 62 (25) 21 (18) 0.381
Hypertension, n (%) 194 (37) 60 (37) 90 (36) 44 (37) 0.953 Dyslipidemia, n (%) 157 (30) 39 (24) 70 (28) 48 (41) 0.009
Diabetes mellitus, n (%) 102 (19) 26 (16) 52 (21) 24 ( (30) 67 (41) 72 (29) 20 (17) II 230 (43) 56 (35) 105 (42) 69 (58) III 83 (16) 17 (10) 43 (17) 23 (19) IV 59 (11) 22 (14) 31 (12) 6 (5) Medical history, n (%)
Atrial fibrillation 160 (30) 46 (28) 80 (32) 34 (29) 
Primary End Point: All-Cause Death
During a median follow-up period of 3.8 years (interquartile range, 1.7-5.7 years), 33 (6.2%) patients reached deaths, of which 25 were cardiac deaths and 8 were not (4 cancers, 1 aortic aneurysm rupture, and 3 unknown cause). Table 2 shows a summary of the incidence of the primary end point. Figure 3A shows the Kaplan-Meier curves for survival free from the primary end point. The 2 positive indices group had more incidents than the other 2 groups (P<0.001). The estimated 5-year rate of the primary end point was the highest in the 2 positive indices group among the 3 groups (18.7%) and lowest in the 2 negative indices group (1.4%; P<0.001; Figure 3C ). 
Principal Secondary End Point: Composite Arrhythmic Events
The composite arrhythmic events occurred in 52 (9.8%) patients ( Table 2 ). The 2 positive indices group had the highest incidents (P<0.001; Figure 3B ) and estimated 5-year rate of this outcome (26.2%; P<0.001; Figure 3D ) among the 3 groups. In contrast, the 2 negative indices group had the much lower incidents and estimated 5-year rate (0.7%) of this outcome than other 2 groups. When we excluded ATP episodes from this outcome, the Kaplan-Meier curves and 5-year rate of composite arrhythmic events were similar ( Figure I in the Data Supplement). In the best predictive model selected by stepwise Cox regression analysis, 2 positive indices status was a significant predictor of a composite arrhythmic events (HR, 9.53; 95% CI, 2.84-31.98; P<0.001; Table IV in the Data Supplement). Higher diagnostic accuracy for composite arrhythmic events was observed with LGE and QRS status than LGE status alone (C-index, 0.721 versus 0.674; P=0.024; Table 4 ). Adding QRS status to a prediction model with LGE status and LVEF ≤35% resulted in significantly better performance for this outcome. The NRI was 50.6% (95% CI, 22.0-79.2; P<0.001).
Device Implantation
During the follow-up period, 97 (18.3%) patients underwent ICD implantation, of whom 68 (70.1%) received events; B) . Kaplan-Meier analysis of all-cause death and the composite arrhythmic events demonstrated significantly worst long-term outcomes in the 2 positive indices group and best in the 2 negative indices groups among the 3 groups. Among the 3 groups, the 5-y event rate of all-cause death (C) and composite arrhythmic events (D) was the highest in the 2 positive indices group and the lowest in the 2 negative indices group. Composite arrhythmic events included sudden cardiac death, nonfatal ventricular fibrillation (Vf), sustained ventricular tachycardia (VT), or appropriate implantable cardiovascular defibrillation discharge for VT or Vf. . 
Cardiac Death and Rehospitalization for HF
During follow-up, 35 (6.6%) cardiac deaths occurred, of which 15 were HF deaths and 20 underwent cardiac transplantation or left ventricular assist device implantation. Among the 3 groups, the 2 positive indices group had the highest incidents (13.6%; P<0.001, Table 2 ; P<0.001, Figure 4A ) and the highest 5-year rate of this outcome (19.3%; P<0.001; Figure 4C) . The best predictive model selected by stepwise Cox regression analysis revealed that 2 positive indices status was a significant predictor of cardiac death (HR, 9.37; 95% CI, 1.18-74.56; P=0.034; Table IV in the Data Supplement). C-index analysis showed that the combination of LGE and QRS status was a more accurate prognostic factor for cardiac death than QRS status alone (0.702 versus 0.610; P=0.012; Table 4 ). A prediction model with the addition of QRS status to LGE status and LVEF ≤35% had significantly higher performance, resulting in NRI of 51.8% (95% CI, 17.5-86.1; P=0.003).
Rehospitalization for HF occurred in 64 (12.0%) patients ( Table 2 ). The 2 positive indices group had the highest incidence (26.3%; P<0.001, Table 2 ; P<0.001, Figure 4B ) and the highest 5-year event rate of this outcome (34.3%; P<0.001; Figure 4D ). In the best predictive model selected by stepwise Cox regression analysis, 2 positive indices status was a significant predictor of rehospitalization for HF (HR, 5.12; 95% CI, 2.00-13.11; P=0.001; Table IV 
Subgroup Analysis: Propensity ScoreMatched Analyses for the All-Cause Death and Composite Arrhythmic Events
To further investigate the prognostic impact of 2 positive indices status on all-cause death and composite arrhythmic events, we evaluated 317 patients who had a class I indication for ICD implantation as primary prevention in a subgroup analysis ( Figure 5 ). Table V in the Data Supplement shows the clinical characteristics of the 3 groups. During the median follow-up period of 3.7 years (interquartile range, 1.9-6.1 years), 28 (8.8%) patients were dead. Among the 3 groups, the 2 positive indices and 2 negative indices groups had the highest and lowest mortalities (P=0.001 , Figure 6A ; P=0.010, Table VI in the Data Supplement) and 5-year mortality rates (P=0.001; Figure 6C ), respectively. The addition of QRS status to the model with LGE status and LVEF resulted in an NRI of 57.3% (95% CI, 18.4-96.3; P<0.001). Meanwhile, 37 (11.7%) patients reached the composite arrhythmic events. Among the 3 groups, the 2 positive indices and 2 negative indices groups also had the highest and lowest rate of incidents (P<0.001, Figure 6B ; P<0.001, Table VI in the Data Supplement) and 5-year rate of composite arrhythmic events (P<0.001; Figure 6D ), respectively. Excluding ATP episodes from this outcome led to similar Kaplan-Meier curves and 5-year rates of composite arrhythmic events ( Figure II Table 5 ). C-index analysis showed that combination of LGE and QRS status had higher diagnostic accuracy of arrhythmic events than LGE status alone (0.733 versus 0.670; P=0.024; Table 6 ). The addition of QRS status to the During the follow-up period, 71 (22.4%) patients underwent ICD implantation, of whom 51 (71.8%) received an ICD plus cardiac resynchronization therapy, 20 (28.2%) received an ICD alone, and 8 (10.1%) received cardiac resynchronization therapy alone before the primary end point occurred. Of the 71 patients who received an ICD, appropriate ICD discharge for VT or Vf occurred in 9 of 27 (33.3%) patients in the 1 positive index group and 15 of 41 (36.6%) patients in the 2 positive indices group. None of the patients experienced an appropriate ICD discharge for VT or Vf in the 2 negative indices group (n=3). However, in the remaining 246 patients without an ICD, 1 of 72 (1.4%) patients in the 2 negative indices group, 3 of 127 (2.4%) patients in the 1 positive index group, and 2 of 47 (4.3%) patients in the 2 positive indices group developed SCD.
In further analysis, propensity score-matched cohorts consisting of 65 patients with 2 negative indices and 65 patients with 1 or 2 positive indices was constructed (Table I in the Data Supplement). In the model that matched for age; sex; NYHA class; heart rate; use of β-blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, diuretics, and amiodarone; left and right ventricular ejection fraction, and left ventricular end-diastolic volume index, there was no significant difference in mortality between the 2 groups. However, composite arrhythmic events occurred less frequently in the 2 negative indices group than in the group with 1 or 2 positive indices (HR, 0.12; 95% CI, 0.01-0.97; P=0.046).
DISCUSSION
The major finding of this study is that the combination of LGE and wQRS allows for reclassification of a substantial number of patients as being at high or low risk for all-cause death. In particular, in DCM patients with a class I indication for ICD implantation as primary prevention (LVEF ≤35% and NYHA class ≥II), the absence of the combination of LGE and wQRS was associated with significantly lower risk of SCD and aborted SCD. This is the first clinical study that demonstrates the incremental value of this combination of minimally invasive physiological (wQRS) and structural (LGE) indices in risk stratification for all-cause death and SCD in patients with DCM. Beyond those identified by risk stratification based on the conventional LVEF cutoff value of 35%, we identified an additional group of patients with DCM who are at low risk of SCD and may not benefit from ICD implantation.
LGE With CMR and Outcome Prediction
Many previous studies have suggested the prognostic value of LGE with CMR in patients with DCM. [4] [5] [6] In particular, Gulati et al 6 suggested that midwall LGE is independently associated with cardiovascular mortality and cardiac transplantation in a large cohort of patients with DCM. More recently, in a meta-analysis that included 2948 patients with nonischemic DCM, Di Marco et al 36 reported that LGE is independently associated with SCD or ventricular arrhythmia. Thus, LGE can potentially improve risk stratification for cardiac events in patients with DCM. However, Schalla et al 37 reported that the presence of fibrosis detected by LGE in patients with DCM is not correlated with the amount of interstitial fibrosis detected by endomyocardial biopsy. In addition, there is some evidence to suggest that interstitial fibrosis is involved in the maintenance of reentry circuits and the generation of focal tachycardias. 38 These findings raise the issue of whether DCM patients without LGE truly need preventive ICD implantation despite having left ventricular dysfunction. To avoid missing patients at high risk for cardiac events who cannot be identified with a binary approach based on LGE status alone, we investigated whether the combination of LGE and QRS status is a better prognostic indicator than LGE status alone.
Prognostic Impact of Wide QRS
QRS duration is a simple measure of the duration of ventricular activation measured on the 12-lead ECG. It is a manifestation of intraventricular or interventricular conduction delay or block. Moreover, it is highly reproducible, with a coefficient of variation of <5%. 39 A previous study suggested that QRS prolongation progresses in DCM; progressive ventricular remodeling is associated with the development of HF. 40 The SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial), which enrolled patients with ischemic and nonischemic cardiomyopathies, reported that ICD therapy yielded a greater reduction in mortality among patients with QRS duration ≥120 ms, but specific information on the relationship between QRS duration and mortal- ity reduction in patients with nonischemic cardiomyopathy was not presented. 41 Recently, Hombach et al 15 showed that in addition to cardiac index and right ventricular end-diastolic volume index derived from CMR imaging, QRS duration >110 ms had prognostic impact on cardiac death and SCD in patients with DCM. More recently, Lund et al 13 reported that QRS duration ≥120 ms is an independent risk factor for all-cause death in DCM (HR, 1.37; 95% CI, 1.31-1.43; P<0.001). Based on these previous studies, we included wQRS in a simple, convenient index for predicting outcomes in patients with DCM. We divided the study patients into 3 groups according to the presence or absence of LGE and wQRS. Indeed, the incidence of the primary and secondary end points was highest in the 2 positive indices group (LGE positive and wQRS group) and lowest in the 2 negative indices group (LGE negative and narrow QRS group). Importantly, the event rate in the 1 positive index group (LGE positive and narrow QRS or LGE negative and wQRS group) was intermediate. The same results were observed in the estimated 5-year rate of the primary and secondary end points, respectively ( Figures 3 and 4) . In addition, the greatest increment in discrimination for predicting all-cause death, composite arrhythmia events, cardiac death, and rehospitalization for HF occurred between patients with 2 positive indices and those with either LGE or QRS status alone (Tables 3 and 4) . Notably, the 2 negative indices group had extremely low incidents for every outcome. Moreover, when we added the presence of wQRS to the model with LGE-positive status and LVEF ≤35%, a further improvement in NRI, 52.5% for all-cause death and 50.6% for composite arrhythmic events, was observed. These results indicate that the combination of LGE and wQRS provides more detailed risk stratification for all-cause death and arrhythmic events in patients with DCM than LGE status alone. This study provides more comprehensive information on how to assess the risk of cardiac events in a broader spectrum of patients with DCM.
Prognostic Impact of the Combination of wQRS and LGE in DCM Patients With a Class I Indication for Prophylactic ICD Implantation
Current international guidelines recommend ICD implantation as primary prevention in DCM patients with LVEF ≤35% and HF symptoms. However, Stecker et al 42 reported that among patients who experienced cardiac arrest, ≈65% of patients would not have qualified for ICD therapy as primary prevention. More recently, the DANISH (Danish Study to Assess the Efficacy of ICDs in Patients With Non-Ischemic Systolic Heat Failure on Mortality) 3 showed that prophylactic ICD implantation did not reduce long-term mortality in patients with nonischemic HF, which includes many patients with DCM, and a class I indication (LVEF ≤35% and NYHA class ≥II) for ICD implantation. However, this trial demonstrated a reduction in SCD in patients with severely reduced LVEF randomized to ICD implantation. This reduction in SCD was not associated with a significant reduction in all-cause death because of high rates of non-SCD and noncardiac death. Thus, that trial has re-emphasized the need to stratify patient at high risk of SCD who may have the most to gain from ICD therapy and those at low risk of SCD who may not have gain from ICD therapy. Indeed, our present study demonstrated that the highest incidence and 5-year rate of all-cause death and the composite arrhythmic events were observed in the 2 positive indices group, whereas arrhythmic events seldom occurred in the 2 negative indices group (Figure 6A-6D) . Furthermore, a propensity score-matched model showed that composite arrhythmic events were significantly less common in the 2 negative indices group than in the group with 1 or 2 positive indices (HR, 0.12; 95% CI, 0.01-0.97; P=0.046). Although further studies are needed, our results suggest a novel way to determine whether ICD implantation is indicated for idiopathic DCM patients who are at high and low risk of SCD based on the minimally invasive indices of QRS duration and LGE status.
Limitations
First, this study was performed in a single high-volume center. Although this enabled the use of a standardized protocol and CMR interpretation by the same independent operators, it introduced the possibility of referral bias. Second, we have not included the impact of different LGE patterns and the LGE border zone on risk classification in our analysis. However, a study 43 have showed that the LGE border zone as assessed by CMR was not superior to the total fibrosis area in identifying individuals with ventricular arrhythmias. Third, diffuse fibrosis, which can be quantified by T1 mapping, 10 is commonly found in patients with DCM. Furthermore, Dass et al 44 suggested that because T1 values determined by T1 mapping are strongly correlated with impaired myocardial energetics, T1 mapping may detect functional changes in the myocardium before the development of fibrosis as evaluated by LGE. Recently, Puntmann et al 45 showed that native T1 mapping is significantly associated with all-cause death and HF events in patients with DCM. However, there is little evidence of incremental value when LGE is already a routine part of the scanning protocol. 45, 46 In addition, unfortunately, it is currently not possible for us to evaluate extracellular volume fraction or native T1 values because CMR examination was performed using a 1.5-T system that is not capable of performing T1 mapping. Therefore, we did not assess extracellular volume fraction or T1 values in this study. Further studies with T1 mapping should investigate the relationship between diffuse fibrosis and cardiac prognosis or wQRS. Fourth, although lower estimated glomerular filtration rate has been reported to be a prognostic factor for cardiac events in patients with chronic HF, patients with chronic renal insufficiency were excluded because of the risk of nephrogenic systemic fibrosis associated with gadolinium exposure. Fifth, the rate of ICD implantation was uneven among the 3 groups. During the follow-up period, ICD implantation was performed based on LVEF, NYHA class, and clinical course. Given the observational nature of this study, there might have been selection bias related to ICD implantation practices. However, uneven rates of ICD implantation have been observed in previous observational studies 6, 47 with a similar study design and primary end point as our present study. Sixth, a relatively low heart rate programming for ICD detection in our series may affect the results by providing unnecessary therapies from ICD for self-terminating VT or Vf. However, this programming trend was observed mainly in secondary prevention patients who were only 15% of the total study subjects, and a detection interval was determined based on the lowest rate of clinical VT in each patient. In primary prevention patients, especially after the shock reduction era, a higher detection rate and longer duration interval were used compared with secondary prevention patients. Finally, the results from the stepwise selection process are potentially biased as a result of overfitting the derivation data set.
Conclusions
The prognostic power of a combination of LGE and wQRS is particularly strong in patients with reduced LVEF. Thus, LGE testing and QRS duration analysis may improve the appropriate use of ICD therapy in patients with idiopathic DCM. 
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